Bristol Myers Squibb Net Non-Operating Interest Income Expense (Quarterly) Analysis

Bristol Myers Squibb Co. (BMY)

54.21 +0.10 (+0.18%) USD | NYSE | Dec 30, 16:00

54.20 0.00 (0.00%) Pre-Market: 06:20

View Net Non-Operating Interest Income Expense (Quarterly) for BMY.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Net Non-Operating Interest Income Expense (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Net Non-Operating Interest Income Expense (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Net Non-Operating Interest Income Expense (Quarterly) Benchmarks

Start Trial

Amgen, Inc.	Upgrade
Gilead Sciences, Inc.	Upgrade
Johnson & Johnson	Upgrade
Eli Lilly & Co.	Upgrade
Regeneron Pharmaceuticals, Inc.	Upgrade